Next-Generation Sequencing – Webinars and Online Events

In this webinar, Dr. Angelo will showcase his research into understanding the evolving spatiotemporal network behind how immune tolerance develops in cancer, pregnancy and TB.

Discover two workflows that incorporate the latest technologies to make your daily routine in the lab easier.

Traditional organoid culture can present challenges for the downstream analysis of single organoids. In this webinar, Dr. Allysa Stern will discuss a unique workflow that enables clonal organoid development, monitoring of iPSC differentiation over time and automated isolation of single organoids.

Dr. Scott Magness will then present a case related to his group’s work investigating tumor cell heterogeneity through clonal organoid morphology and transcriptomics. He will discuss new approaches using single organoid transcriptomics to evaluate organoids derived from single cells from gastric dysplastic tissues and how this approach might reveal new ways to investigate tumor cell heterogeneity and evasion of some cells from cancer treatments.

In this webinar, our expert speaker, Vanessa Porter, will present her research into identifying and classifying genomic perturbations arising from HPV integration.

Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Karsten Strauss from Olink delivered his talk on how Olink are able to provide a platform of products and services that are deployed across major pharmaceutical companies.

This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.

Over recent years, genomic sequencing of pathogens has emerged as a powerful tool to guide public health action by providing a deeper understanding of pathogen evolution, emerging variants and transmission dynamics. Oxford Nanopore Technologies offers an accessible, all-in-one sequencing platform that enables rapid, distributed and scalable genomic pathogen surveillance.

In this webinar, you will hear from leaders in the field of microbiology and infectious disease research, who will share their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing. The protocols presented in this webinar can be leveraged for targeted whole genome sequencing of different viral pathogens such as SARS-CoV-2 and monkeypox virus, as well as more broadly for the genomic characterization of known and novel viruses in an untargeted manner.

Attend this webinar to:
- Overcome key challenges when working with rare antigen-specific T cells
- Learn the key considerations when preparing samples for single-cell sequencing
- Gain insights into tumor single-cell sequencing results

With the genetics behind cancer being both diverse and complex, there are many genomic deviations that need to be detected and analyzed to further our understanding of the disease. Using nanopore sequencing, scientists can achieve the most comprehensive insight into cancer genomes. To explore this further, this symposium will bring together experts in cancer research, where they’ll cover how they are using the technology.

The speakers will discuss detecting missing structural variants, characterizing mutation patterns and how nanopore sequencing has advanced their research.

Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.